| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/16/2001 | EP0688330B1 New o-sulfated gangliosides and lyso-ganglioside derivatives |
| 08/16/2001 | EP0684820B1 Biologically active 3-substituted oxindole derivatives useful as anti-angiogenic agents |
| 08/16/2001 | EP0677050B1 Novel pyridone carboxylic acid derivatives |
| 08/16/2001 | EP0649309B1 Use of particles of a biocompatible, bioabsorbable calcium salt as active principle in the preparation of a medicament for local treatment of bone demineralizing diseases |
| 08/16/2001 | EP0628042B1 Serotoninergic ergoline derivatives |
| 08/16/2001 | EP0558677B1 Biologically active amines |
| 08/16/2001 | DE10006836A1 Therapeutic treatment of bed-wetting using polyunsaturated fatty acids, e.g. eicosapentaenoic acid, administered as capsules containing fish oil concentrate |
| 08/16/2001 | DE10006139A1 Indol-3-yl-Derivate Indol-3-yl derivatives |
| 08/16/2001 | DE10004769A1 Compact hairspray, comprises a concentrate of a polymer(s), an inert alcoholic solvent and a second organic solvent, a container and a fine spray pump and a pressure device |
| 08/16/2001 | DE10004651A1 Kombination von blutdrucksenkenden Wirkstoffen mit Wirkstoffen, die den Homocysteinspiegel zu senken vermögen Combination of antihypertensive agents with agents that are able to reduce homocysteine levels |
| 08/16/2001 | DE10003835A1 Formulierungen bei Dehydratationszuständen Formulations for dehydration conditions |
| 08/16/2001 | CA2736615A1 Method for classifying and treating physiologic brain imbalances using quantitative eeg |
| 08/16/2001 | CA2714081A1 Methods and compositions for treating conditions of the eye |
| 08/16/2001 | CA2635489A1 Drug delivery apparatus |
| 08/16/2001 | CA2416343A1 Substituted 1,2,3,4-tetrahydroquinoline-2-carboxylic acid derivatives |
| 08/16/2001 | CA2400699A1 Therapeutic and diagnostic methods for ulcerative colitis and associated disorders |
| 08/16/2001 | CA2400497A1 Methods and compositions for generating angiostatin |
| 08/16/2001 | CA2400472A1 Il-17 like molecules and uses thereof |
| 08/16/2001 | CA2400323A1 Ocular hypotensive lipids |
| 08/16/2001 | CA2400299A1 Dna encoding human vanilloid receptor vr3 |
| 08/16/2001 | CA2400243A1 A treatment agent for osteoarthritis |
| 08/16/2001 | CA2400092A1 Diagnostic and therapeutic compositions and methods for affecting tumor growth using oxygen mimetic agents |
| 08/16/2001 | CA2399939A1 Partners of ptb1 domain of fe65, preparation and uses |
| 08/16/2001 | CA2399800A1 Remedies for sjoegren's syndrome |
| 08/16/2001 | CA2399799A1 2-phenylcarbamoyl-benzimidazoles |
| 08/16/2001 | CA2399795A1 2-carboxamide-benzimidazoles useful in the treatment and prevention of ischemic reperfusion injury |
| 08/16/2001 | CA2399791A1 Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators in treating respiratory and non-respiratory diseases |
| 08/16/2001 | CA2399689A1 Gene cluster encoding a nystatin polyketide synthase and its manipulation and utility |
| 08/16/2001 | CA2399623A1 Differentiation of bone marrow cells into neuronal cells and uses therefor |
| 08/16/2001 | CA2399593A1 Antibodies to ccr5 |
| 08/16/2001 | CA2399486A1 Use of compatible solutes as inhibitors of the enzymatic decomposition of macromolecular biopolymers |
| 08/16/2001 | CA2399463A1 Combination drug |
| 08/16/2001 | CA2399421A1 Compounds useful for the treatment or prevention of a disease mediated by the alpha-2b-adrenoceptor |
| 08/16/2001 | CA2399411A1 Water dispersible formulation of paroxetine |
| 08/16/2001 | CA2399402A1 Use of cyp1b1 inhibitors for treating cancer |
| 08/16/2001 | CA2399396A1 Tnf- .alpha. inhibitors |
| 08/16/2001 | CA2399391A1 Trade molecules and uses related thereto |
| 08/16/2001 | CA2399380A1 Pyrrolopyridazine compound |
| 08/16/2001 | CA2399367A1 Pharmaceutical composition for pulmonary delivery |
| 08/16/2001 | CA2399349A1 Novel elongase gene and method for producing multiple-unsaturated fatty acids |
| 08/16/2001 | CA2399136A1 1h-imidazopyridine derivatives |
| 08/16/2001 | CA2398984A1 Use of glutamate and/or a glutamate precursor for the preparation of a nutritional or pharmaceutical preparation for the treatment or prevention of hyperpermeability or undesired permeability of the intestinal wall |
| 08/16/2001 | CA2398956A1 A pharmaceutical composition for prophylaxis or therapy of a postoperative stress |
| 08/16/2001 | CA2398923A1 A group of anti-cancer compounds with specific structure and their production method |
| 08/16/2001 | CA2398840A1 Method to potentiate the therapeutic efficacy of taxane and derivatives thereof |
| 08/16/2001 | CA2398822A1 Piperazine and piperidine derivatives |
| 08/16/2001 | CA2398775A1 Inhibitor of hepatocyte growth factor activator for use in modulation of angiogenesis and cardiovascularization |
| 08/16/2001 | CA2398750A1 Nucleozymes with endonuclease activity |
| 08/16/2001 | CA2398567A1 Methods for enhancing the bioavailability of a drug |
| 08/16/2001 | CA2398282A1 Method and reagent for the modulation and diagnosis of cd20 and nogo gene expression |
| 08/16/2001 | CA2398184A1 Method and compositions for treating an inflammatory disease |
| 08/16/2001 | CA2398170A1 An essential constituent and method of use for maintaining hair coloration or reversing hair discoloration |
| 08/16/2001 | CA2398158A1 Ophthalmic use of alpha adrenergic blocking agents |
| 08/16/2001 | CA2398007A1 Use of pyrimidine endothelin antagonists in companion animals |
| 08/16/2001 | CA2397993A1 Dehydroamino acids |
| 08/16/2001 | CA2395648A1 Oxazolidinone thioamides with piperazine amide substituents |
| 08/15/2001 | CN1308682A Fermentation process to produce clavulanic acid at a low concentration of free amino acids |
| 08/15/2001 | CN1308677A Human tumour-derived polyptde hormone phosphatonin |
| 08/15/2001 | CN1308675A Immunological reagent specifically interating with the extracellular domain of the human zeta chain |
| 08/15/2001 | CN1308637A Binding molecules derived from immunolobulins which do not trigger complement mediated lysis |
| 08/15/2001 | CN1308632A 'Beta'-carboline compound |
| 08/15/2001 | CN1308631A Heterocyclic derivatives which inhibit factor xa |
| 08/15/2001 | CN1308630A Benzocarbazole and indenoindole derived estrogenic agents |
| 08/15/2001 | CN1308629A Reduced partide size form of 1-(6-chloronaphth-2-ylsulphonyl)-4-[4-(4-pyridyl)benzoyl] piperazine |
| 08/15/2001 | CN1308627A 11-Aryl-benzo[b]naphtho[2,3-d]furans and 11-aryl-aryl-benzo[b]anphtho[2,3-d]thiophenes useful in the treatment of insulin resistance and hyperglycemia |
| 08/15/2001 | CN1308626A Benzothiophenes, benzofurans, and indoles useful in the treatment of insulin resistance and hyperglycemia |
| 08/15/2001 | CN1308625A Naphtho [2,3-b] heteroar-4-yl derivatives |
| 08/15/2001 | CN1308624A Novel polyoxypropylenepolyoxyethylene vitamin E and preparation thereof |
| 08/15/2001 | CN1308622A Biphenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia |
| 08/15/2001 | CN1308621A Phenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia |
| 08/15/2001 | CN1308620A Biphenyl sulfonyl aryl carboxylic acids useful in the treatment of insulin resistance and hyperglycemia |
| 08/15/2001 | CN1308619A (2-acylaminothiazole-4-yl) acetic acid derivatives |
| 08/15/2001 | CN1308618A Oxazole-aryl-carboxylic acids useful in the treatment of insulin resistance and hyperglycemia |
| 08/15/2001 | CN1308617A Antiviral macrocyclic compounds |
| 08/15/2001 | CN1308616A Non-peptidyl inhibitors and VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory disease |
| 08/15/2001 | CN1308614A Benzimidazoles, production thereof and use thereof medicaments |
| 08/15/2001 | CN1308611A Antihistaminic piperidine derivatives and intermediates for the preparation thereof |
| 08/15/2001 | CN1308609A Method of locking 1 & alpha, -OH of vitamin d compounds in axial orientation |
| 08/15/2001 | CN1308608A Substituted beta-amino acid inhibitors of methionine aminopeptidase-2 |
| 08/15/2001 | CN1308606A Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use pharmaceutical preparations comprising them |
| 08/15/2001 | CN1308604A 2,3,5-substituted biphenyls useful in the treatment of insulin resistance and hyperglycemia |
| 08/15/2001 | CN1308545A Method of increasing bone toughness and stiffness and reducing fractures |
| 08/15/2001 | CN1308542A Sucoinamide inhibitors of interleukin-1& beta, converting enzyme |
| 08/15/2001 | CN1308541A Extracts of zanthoxylum bungeanum, pharmaceuti-cal and cosmetic formulations containing them |
| 08/15/2001 | CN1308539A Process for producing an iron-dextran compound |
| 08/15/2001 | CN1308538A Treatment of hyperproliferative disorders |
| 08/15/2001 | CN1308537A Steroid-containing cataplasms and process for producing the same |
| 08/15/2001 | CN1308536A Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| 08/15/2001 | CN1308535A Farnesyl protein transferase inhibitors for treating arthropathies |
| 08/15/2001 | CN1308534A Angiogenesis inhibitors |
| 08/15/2001 | CN1308533A Agent with an antidepressive effect |
| 08/15/2001 | CN1308532A Mycobacterial inhibitors |
| 08/15/2001 | CN1308531A Vitamin E and esters thereof for use in the topical treatment of mucosal pathologies |
| 08/15/2001 | CN1308530A Use of tricyclic antidepressants for local analgesia |
| 08/15/2001 | CN1308528A Plaster which contains steroids, and method for the production and use thereof |
| 08/15/2001 | CN1308527A Topical plaster with non-steroidal antirheumatic agents with an acid group |
| 08/15/2001 | CN1308526A Composition containing glycerol trinitrate, method for producing said composition and use of the same |
| 08/15/2001 | CN1308525A Transdermal plaster containing at least one active ingredient which infuences blood serum lipid levels |
| 08/15/2001 | CN1308523A Pellets having a core coated with a lipid lowering agent and a polymer |
| 08/15/2001 | CN1308522A Thixotropic formulations for filling capsules |